Kusajili – Clinical trials directory

Result of your search per sponsor: Merck Serono S.A.-Geneva, an affiliate of Merck KGaA Darmstadt, Germany

Woman and Man Max 99 years
Merck Serono S.A.-Geneva, an affiliate of Merck KGaA Darmstadt, Germany Update Il y a 4 ans

A randomised, double-blind, placebo-controlled, multicentre prospective dose-finding Phase II/III study with atacicept given subcutaneously to subjects having recently experienced a flare of systemic lupus erythematosus (SLE) The primary objective of this trial is to evaluate the efficacy of atacicept compared to placebo in preventing new flares in subjects with SLE.

Country None
organs None
Specialty None

Closed trial

More information

Woman and Man Max 99 years
Merck Serono S.A.-Geneva, an affiliate of Merck KGaA Darmstadt, Germany Update Il y a 4 ans

A phase III, randomized, double-blind, placebo-controlled, multicenter clinical trial of Rebif New Formulation (44 mcg tiw and 44 mcg ow) in subjects at high risk of converting to Multiple Sclerosis The primary objective of the study is to evaluate the effect of Rebif New Formulation 44 mcg (tiw and ow) versus placebo on the time to conversion to McDonald MS in patients with a first clinical demy...

Country None
organs None
Specialty None

Closed trial

More information